Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Catalent Invests $350 million in Drug Manufacturing Facility in Indiana
Catalent is investing US$350 million in Bloomington, Indiana to expand its biologics drug substance and therapeutic product manufacturing capabilities The project will support the industrys extensive biologics pipeline in a variety of ways Additionally, bioreactors, syringe filling lines, and lyophilization capacity
Seagen Plans Expansion of Cancer Biomanufacturing Facility in Washington
Seagen intends to expand its manufacturing facilities to gain more control and flexibility over the production of its cancer medications The 270,000squarefoot complex will be constructed north of the companys North American headquarters in Bothell, Washington
BIOVECTRA Starts Work on mRNA Vaccine and Biomanufacturing Facility in Charlottetown
The mRNA Vaccine and Biomanufacturing Centre at Biovectras Charlottetown campus has begun development The 36,000squarefoot facility will be able to produce 160 million doses of mRNA vaccines per year, with 70 million doses packed and ready for commercial distribution
